Pulmonx (LUNG) EBT (2019 - 2025)

Pulmonx (LUNG) has 7 years of EBT data on file, last reported at -$13.8 million in Q3 2025.

• On a quarterly basis, EBT rose 0.88% year-over-year to -$13.8 million in Q3 2025; TTM through Sep 2025 was -$56.3 million, a 0.22% change from a year earlier, with the FY2024 full-year figure at -$55.9 million, up 7.26% from the prior year.
• EBT for Q3 2025 stood at -$13.8 million, up from -$15.0 million in the prior quarter.
• Over the last five years, EBT for LUNG reached as high as -$10.1 million in Q3 2021 and fell as low as -$16.1 million in Q2 2023.
• Historically, EBT has averaged -$14.0 million across 5 years, with a median of -$14.0 million in 2022.
• Across the five-year window, EBT slumped 165.99% in 2021 and grew 13.81% in 2024, its largest moves.
• Year by year, EBT stood at -$12.9 million in 2021, then retreated by 9.2% to -$14.0 million in 2022, then rose by 2.83% to -$13.6 million in 2023, then gained by 3.69% to -$13.1 million in 2024, then declined by 5.27% to -$13.8 million in 2025.
• Per Business Quant data, the three most recent EBT figures were -$13.8 million in Q3 2025, -$15.0 million in Q2 2025, and -$14.3 million in Q1 2025.